Bank of America Initiates Coverage on resTORbio (TORC)
Analysts at Bank of America began coverage on shares of resTORbio (NASDAQ:TORC) in a research note issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Bank of America’s target price would suggest a potential upside of 16.81% from the company’s current price.
Separately, Evercore ISI assumed coverage on shares of resTORbio in a research note on Tuesday. They issued an “outperform” rating and a $28.00 target price on the stock.
Shares of resTORbio (NASDAQ TORC) opened at $19.69 on Tuesday. resTORbio has a 52 week low of $15.18 and a 52 week high of $20.50.
TRADEMARK VIOLATION WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/bank-of-america-initiates-coverage-on-restorbio-torc/1881486.html.
resTORbio, Inc is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. It focuses on the mechanistic target of rapamycin (mTOR) pathway that regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1 (TORC1).
Receive News & Ratings for resTORbio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for resTORbio and related companies with MarketBeat.com's FREE daily email newsletter.